4CR5

Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2015-02-11	Initial release			Download
2.0	2018-04-04		Advisory, Atomic model, Data collection	atom_site, diffrn_source, pdbx_unobs_or_zero_occ_atoms
2.1	2024-10-16		Data collection, Database references, Derived calculations, Other, Structure summary	chem_comp_atom, chem_comp_bond, database_2, pdbx_database_status, pdbx_entry_details, pdbx_modification_feature, struct_site	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.